NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy. - a podcast by The New England Journal of Medicine

Dr. Julie Gerberding is chief patient officer and executive vice president at Merck. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Gerberding and B.F. Haynes. Vaccine Innovations — Past and Future. N Engl J Med 2021;384:393-396.

Further episodes of 301 Moved Permanently

Further podcasts by The New England Journal of Medicine

Website of The New England Journal of Medicine